Profile
PFSA LH NVST HIMS CON BBNX
Company Name Profusa, Inc. Common Stock Labcorp Holdings Inc. Envista Holdings Corp Hims & Hers Health, Inc. Concentra Group Holdings Parent, Inc. Beta Bionics, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services
Market Cap $1.68M $23.06B $4.78B $3.46B $3.06B $621.63M
Employees 0.00K 60.90K 12.30K 1.64K 8.76K 0.35K
CEO Ben Chung-Bin Hwang Adam H. Schechter Paul A. Keel Andrew Dudum William Keith Newton Sean T. Saint
Ratings
PFSA LH NVST HIMS CON BBNX
Quant Rating Score 2 3 3 2 2 2
Quant Rating Sell Neutral Neutral Sell Sell Sell
Trading
PFSA LH NVST HIMS CON BBNX
Last Close $0.1751 $261.37 $19.11 $35.58 $19.24 $27.16
High 52 $2.01 $290.93 $22.33 $68.74 $23.8 $28.84
Low 52 $0.18 $212.22 $14.78 $21.79 $18.71 $9.71
Price vs. 52 Week High -91.29 % -10.16 % -14.42 % -48.24 % -19.16 % -5.83 %
Price vs. 52 Week Low -2.72 % 23.16 % 29.3 % 63.29 % 2.83 % 179.71 %
Total Return
PFSA LH NVST HIMS CON BBNX
1 Month Return -41.1 % -8.59 % -4.26 % -28.53 % -3.41 % 35.66 %
3 Month Return -68.73 % -3.37 % -7.95 % -21.09 % -15.87 % 57.36 %
6 Month Return 0 % 4.75 % 4.6 % -44.97 % -15.32 % 89.14 %
9 Month Return 0 % 6.12 % -13.72 % -39.18 % -17.32 % 24.05 %
YTD Return 0 % 13.98 % -0.93 % 47.15 % -2.73 % 0 %
1 Year Return 0 % 10.64 % -5.68 % 51.21 % -5.08 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PFSA LH NVST HIMS CON BBNX
Dividend Yield Percentage (TTM) - 1.04 % - - 1.05 % -
Dividend Paid and Capex Coverage Ration (TTM) -2324215 % 2.72 % 7.98 % 1.68 % 2.3 % -14.31 %
Dividend Per Share (TTM) - 2.88 % - - 0.25 % -
Payout Ratio (TTM) - 28.24 % - - 19.06 % -
Growth
PFSA LH NVST HIMS CON BBNX
Asset Growth 62.33 % 9.89 % -18.99 % 60.37 % - 35.99 %
Gross Profit Growth - 7.71 % -4.06 % 64.09 % -100 % 468.93 %
Revenue Growth - 6.97 % -2.18 % 69.33 % -100 % 442.93 %
Revenue 3 Year - 14.14 % -6.32 % 369.75 % -100 % 28465.39 %
Revenue 5 Year - 31.37 % -13.09 % 187.88 % -100 % 28465.39 %
Revenue 10 Year - 118.72 % -19.08 % 187.88 % -100 % 28465.39 %
EBIT Growth 19.87 % 51.96 % -52.23 % 310.18 % -100 % -26.22 %
Net Income Growth 10.22 % 78.47 % -1016.37 % 635.28 % 5.69 % -24.17 %
Net Income 3 Yeari Growth Per Share 10.48 % -63.83 % -407.53 % 201.26 % -100 % 33.6 %
Net Income 5 Yeari Growth Per Share 10.48 % 5.67 % -506.59 % 128.15 % -100 % 33.6 %
Net Income 10 Yeari Growth Per Share 10.48 % 47.5 % -469.22 % 128.15 % -100 % 33.6 %
Operating Income Growth 25.86 % 49.77 % -3395.87 % 310.18 % -100 % -26.22 %
Operating Cash Flow Growth (CFG) 53.07 % 19.44 % 22.05 % 241.69 % 1.72 % -48.78 %
Operating 3 Year CFG 80.68 % -41.22 % -12.89 % 731.12 % -100 % 37.05 %
Operating 5 Year CFG 80.68 % 28.08 % -33.04 % 153.98 % -100 % 37.05 %
Operating 10 Year CFG 80.68 % 116.89 % -27.55 % 153.98 % -100 % 37.05 %
EPS Growth 9.68 % 85.21 % -983.33 % 627.27 % -100 % -3.49 %
EPS Diluted Growth 9.68 % 85.32 % -983.33 % 581.82 % -100 % -3.49 %
Book Value Per Share -8.37 % 6.13 % -31.85 % 34.34 % -100 % 8.07 %
Share Holder 3 Year Equity Growth Per Share -42.49 % -9.66 % -32.29 % 23.23 % -100 % 359.09 %
Share Holder 5 Year Equity Growth Per Share -42.49 % 24.17 % -34.43 % 156.72 % - 359.09 %
Share Holder 10 Year Equity Growth Per Share -42.49 % 188.55 % - 156.72 % - 359.09 %
Dividend Per Share Growth - -0.64 % - - -100 % -
Dividend 3 Year Growth Per Share - - - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - - - - - -
Debt Growth 19.34 % 22.15 % -6.4 % 14.04 % - 71.8 %
Free Cash Flow Growth 53.09 % 25.37 % 39.17 % 322.07 % 32.83 % -57.3 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2025 31 Dec 2024
Profitability
PFSA LH NVST HIMS CON BBNX
Gross Profit Margin TTM - 28.45 % 54.75 % 75.01 % 21.83 % 54.51 %
Return on Assets TTM -957.41 % 4.68 % 0.83 % 5.99 % 5.9 % -23.59 %
Return on Equity TTM 89.59 % 10.2 % 1.52 % 24.67 % 51.22 % -31.57 %
Return on Capital Employed TTM 126.54 % 8.53 % 4.48 % 6.45 % 30.94 % -22.52 %
Net Income Per EBT TTM 100.05 % 77.7 % 26.52 % 104.64 % 74.99 % 100 %
EBT Per Ebit TTM 166.62 % 82.54 % 82 % 111.16 % 28.58 % 113.48 %
EBIT Per Revenue TTM - 9.69 % 7.95 % 5.2 % 36.2 % -77.45 %
Cash Flow To Debt Ratio TTM -55.15 % 27.62 % 18.78 % 29.08 % 11.88 % -736.01 %
Receivables Turnover TTM - 6.08 6.33 53.49 7.76 6.21
Payables Turnover TTM - 14.73 6.42 2.78 35.13 9.03
Inventory Turnover TTM - 18.89 4.27 5.21 - 1.98
Fixed Asset Turnover TTM - 442.22 % 619.62 % 543.59 % 304.09 % 614.69 %
Asset Turnover TTM - 75.38 % 47.89 % 99 % 76.07 % 26.84 %
Operating Cash Flow Per Share TTM -27.47 21.7 1.83 1.44 2.01 -1.3
Free Cash Flow Per Share TTM -27.47 16.62 1.6 0.58 1.39 -1.39
Cash Per Share TTM 940.95 % 719.74 % 737.04 % 278.22 % 39.43 % 524.1 %
Operating Cash Flow Sales Ratio TTM - 13.1 % 11.04 % 14.7 % 11.76 % -63.88 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 76.56 % 87.47 % 40.46 % 69.01 % 106.99 %
Cash Flow Coverage Ratios TTM -55.15 % 27.62 % 18.78 % 29.08 % 11.88 % -736.01 %
Price To Free Cash Flows Ratio TTM -0.14 16.7 18.23 26.34 17.44 -10.27
Price To Operating Cash Flows Ratio TTM -0.11 12.81 15.94 11 11.89 -10.89
Price Cash Flow Ratio TTM -0.11 12.81 15.94 11 11.89 -10.89
Income Statement (TTM)
PFSA LH NVST HIMS CON BBNX
Revenue $0B $13.01B $2.72B $1.48B $2.16B $0.07B
Gross Profit $0B $3.62B $1.5B $1.17B $0B $0.04B
Gross Profit Ratio 0% 27.86% 55.02% 79.45% 0% 55.11%
EBITDA $-0B $1.81B $0.34B $0.08B $2.16B $-0.04B
Net Income $-0.01B $0.75B $0.05B $0.13B $0.17B $-0.05B
EPS Diluted -21 8.84 0.28 0.53 1.37 -8.6
Balance Sheet (MRQ)
PFSA LH NVST HIMS CON BBNX
Long Term Debt $0B $6.08B $1.67B $0.01B $1.87B $0.01B
Total Liabilities $0.12B $10.31B $2.57B $0.23B $2.22B $0.07B
Total Equity $-0.12B $8.07B $3.11B $0.48B $0.3B $0.08B
Total Investments $0B $0.02B $0B $0.08B $0B $0.07B
Total Debt $0.05B $7.27B $1.6B $0.01B $1.95B $0.01B
Total Assets $0B $18.38B $5.68B $0.71B $2.52B $0.15B
Cash Flow Statement (TTM)
PFSA LH NVST HIMS CON BBNX
Net Income $-0.01B $0.75B $0.05B $0.13B $0.17B $-0.05B
Inventory $0B $-0.01B $-0.03B $-0.04B $0B $-0.01B
Dividends Paid $0B $-0.24B $0B $0B $0B $0B
Operating Cash Flow $-0B $1.59B $0.28B $0.25B $0.28B $-0.05B
Capital Expenditure $0B $-0.49B $-0.05B $-0.05B $0B $-0B
Related Stocks
Ticker Name Price
BBNX Beta Bionics, Inc. Common Stock 13.55
CON Concentra Group Holdings Parent, Inc. 23.89
HIMS Hims & Hers Health, Inc. 15.8
KDLY Kindly MD, Inc. Common Stock 11.3
LH Laboratory Corporation of America Holdings 278.11
NAKA KindlyMD, Inc. 0.2765
NEUE NeueHealth, Inc. 6.753
NVST Envista Holdings Corporation 28.77
PARK Park Dental Partners, Inc. Common Stock 18.38
ETFs With Exposure to PFSA
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0.00004 213.85
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00004 162.32
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00004 162.33
VEMPX Vanguard Extended Market Index InstlPlus 0.00004 400.57
Unlock